Evaluation of the Pharmacokinetics and the Pharmacodynamics of Different Dry Powder Inhalation Formulations of AZD3199 in Patients With Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Asthma
Interventions
DRUG

AZD3199

Inhaled via single inhaler device (SID)

DRUG

AZD3199

Inhaled via Turbuhaler inhaler

OTHER

AZD3199 Placebo

Inhaled via Turbuhaler inhaler and SID

Trial Locations (3)

Unknown

Research Site, Gothenburg

Research Site, Luleå

Research Site, Lund

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY